Bill Status of SB3801

  1. Home
  2. Legislation
  3. Bill Status

SB3801 - 104th General Assembly

PRESCRIPTION LABELING
Last Action
3/11/2026 - Senate: Postponed - Executive
Statutes Amended In Order of Appearance
225 ILCS 60/33from Ch. 111, par. 4400-33
225 ILCS 85/22from Ch. 111, par. 4142
Synopsis As Introduced
Amends the Medical Practice Act of 1987. In provisions concerning legend drugs, provides that, at the request of a person dispensing a drug or medicine, the label affixed to a box, bottle, vessel, or package containing mifepristone, misoprostol, or any generic alternative may include the name of the dispensing health care practice instead of the name of the person dispensing the drug or medicine. Amends the Pharmacy Practice Act. In provisions concerning the label of a drug, medicine, or poison that is lawfully sold or dispensed, provides that, at a prescriber's request, the label affixed to a box, bottle, vessel, or package containing mifepristone, misoprostol, or any generic alternative may include the name of the prescribing health care practice instead of the name of the prescriber.
Actions
Date Chamber Action
2/06/2026 Senate Filed with Secretary by Sen. Celina Villanueva
2/06/2026 Senate First Reading
2/06/2026 Senate Referred to Assignments
2/11/2026 Senate Added as Co-Sponsor Sen. Rachel Ventura
2/24/2026 Senate Assigned to Executive
2/25/2026 Senate Added as Co-Sponsor Sen. Suzy Glowiak Hilton
2/27/2026 Senate Added as Co-Sponsor Sen. Mark L. Walker
3/05/2026 Senate Added as Co-Sponsor Sen. Adriane Johnson
3/11/2026 Senate Postponed - Executive
3/13/2026 Senate Rule 2-10 Committee Deadline Established As March 27, 2026